# ETHICAL REFLECTION
## Potential Biases in the Dataset

- In the breast cancer classification model, bias could arise if the dataset contains unequal representation of patients. For example, more benign cases than malignant ones, or data collected mostly from a particular age group, ethnicity, or medical center. Such imbalance can cause the model to perform better on the majority class (e.g., benign tumors) and worse on underrepresented cases (e.g., rare or aggressive malignant types). This leads to skewed predictions and potentially life-impacting misclassifications.

- Another possible bias is sampling bias. i.e if the images were captured using specific imaging devices or under consistent lighting conditions, the model may fail to generalize well to images from other hospitals or different equipment setups.

## Using Fairness Tools like IBM AI Fairness 360

### The IBM AI Fairness 360 (AIF360) toolkit can help identify and reduce these biases in medical imaging datasets. It can:

- Detect bias: Compute fairness metrics to see if the model’s accuracy or false-negative rate differs across patient subgroups (e.g., gender, age, or hospital source).

- Mitigate bias: Apply methods like reweighing (assigning higher importance to underrepresented samples) or resampling to balance the dataset before training.

- Monitor fairness: Provide continuous evaluation of fairness metrics after each training iteration to ensure that improvements in accuracy do not come at the cost of equity between subgroups.

Using such tools ensures that the breast cancer classifier not only achieves high performance but also provides trustworthy and unbiased diagnostic support, reducing the risk of unequal healthcare outcomes.